MC
MEDP icon

McMorgan & Co’s Medpace MEDP Stock Holding History

McMorgan & Co’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,395
Closed -$2.95M – 60
2025
Q2 		$2.95M Buy
9,395
+215
+2% +$64.5K 0.43% 30
2025
Q1 		$2.8M Sell
9,180
-305
-3% -$103K 0.45% 28
2024
Q4 		$3.15M Sell
9,485
-70
-0.7% -$23.7K 0.49% 29
2024
Q3 		$3.19M Hold
9,555
– – 0.49% 30
2024
Q2 		$3.94M Buy
9,555
+358
+4% +$142K 0.62% 26
2024
Q1 		$3.72M Sell
9,197
-36
-0.4% -$12.7K 0.64% 24
2023
Q4 		$2.83M Buy
9,233
+265
+3% +$71.5K 0.47% 26
2023
Q3 		$2.17M Sell
8,968
-1,297
-13% -$332K 0.4% 27
2023
Q2 		$2.47M Buy
10,265
+665
+7% +$138K 0.46% 23
2023
Q1 		$1.81M Sell
9,600
-142
-1% -$29.4K 0.37% 27
2022
Q4 		$2.07M Sell
9,742
-2,278
-19% -$455K 0.44% 22
2022
Q3 		$1.89M Sell
12,020
-320
-3% -$51.1K 0.45% 22
2022
Q2 		$1.85M Buy
12,340
+6,650
+117% +$963K 0.41% 21
2022
Q1 		$931K Sell
5,690
-170
-3% -$28K 0.2% 44
2021
Q4 		$1.27M Buy
5,860
+1,010
+21% +$211K 0.22% 39
2021
Q3 		$918K Buy
+4,850
New +$885K 0.18% 41

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

McMorgan & Co's MEDP Position: Q3 2025 in Review

McMorgan & Co sold out of Medpace (MEDP) in Q3 2025, closing a stake of 9,395 shares — an estimated $2.95M sold.

McMorgan & Co first reported a position in MEDP in Q3 2021 and held it in 16 quarters. The position peaked at $3.94M in Q2 2024. 673 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • McMorgan & Co reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • McMorgan & Co sold 9,395 Medpace shares in Q3 2025, an estimated $2.95M.
  • McMorgan & Co first reported a position in Medpace in Q3 2021 and held it in 16 quarters.
  • McMorgan & Co's Medpace position peaked at $3.94M in Q2 2024.
  • 673 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on McMorgan & Co's 13F filing for Q3 2025, filed 12 Nov 2025.